Clinical characteristics and risk factors for survival in affected offspring of von Hippel-Lindau disease patients
Open Access
- 16 December 2021
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 59 (10) , 951-956
Abstract
Background Von Hippel-Lindau (VHL) disease is an autosomal dominant genetic tumour syndrome with poor prognosis. The clinical manifestation was found to be more serious in affected offspring of patients with VHL disease, but the risk factors and survival for them have never been reported before. We aimed to explore how these patients were influenced by genetic and clinical factors. Methods In this retrospective study, we collected 372 affected offspring of VHL patients from 118 unrelated VHL families. Patients were stratified into different groups based on sets of variables. The age-related risk, overall survival and central nervous systemhaemangioblastoma (CHB)-specific survival were analysed between different groups using Kaplan-Meier survival analysis and Cox regression analysis. Results The estimated median life expectancy and median age of onset for affected offspring of VHL patients were 66 years and 28 years, respectively. The later generation and patients with mutations in exon 3 had an earlier onset age. The first presenting symptom was the only independent risk factor influencing overall survival and CHB-specific survival. Patients that the first presenting symptom is central nervous system (CNS) significantly had a lower life expectancy both in overall survival and CHB-specific survival analysis than abdominal lesions group. Conclusion This study indicated that affected offspring of VHL patients with CNS as the first presenting symptom was an independent risk factor for overall survival and CHB-specific survival. Generation and mutation region only had an effect on the onset age, which is helpful to clinical decision-making and generate a more precise surveillance protocol.Keywords
This publication has 33 references indexed in Scilit:
- Genetic Anticipation Is Associated with Telomere Shortening in Hereditary Breast CancerPLOS Genetics, 2011
- Identification and In Silico Analysis of Novel von Hippel-Lindau (VHL) Gene Variants from a Large PopulationAnnals of Human Genetics, 2011
- von Hippel–Lindau disease: A clinical and scientific reviewEuropean Journal of Human Genetics, 2011
- VHL DiseaseBest Practice & Research Clinical Endocrinology & Metabolism, 2010
- Neurologic Manifestations of von Hippel-Lindau DiseaseJAMA, 2008
- Evidence for genetic anticipation in hereditary non-polyposis colorectal cancerHuman Genetics, 2005
- The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinomaOncogene, 2001
- Haemangioblastoma of the central nervous system in von Hippel–Lindau diseaseJournal of Internal Medicine, 1998
- A genetic register for von Hippel-Lindau disease.Journal of Medical Genetics, 1996
- Von Hippel-Lindau disease: a genetic study.Journal of Medical Genetics, 1991